Thus, we believe co-occurring mutations other than chromosome 1p loss, TERT mutation, CDKN2A/B loss can stratify NF2 mutated meningiomas, although a larger data set is required to confirm this hypothesis. This evidence concerns the gene NF2 and meningioma.